Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3961805 | Journal of Minimally Invasive Gynecology | 2015 | 6 Pages |
Abstract
LRH is adequate, safe, and feasible for women with cervical cancer, and it can be routinely used for the treatment of early-stage tumors as a primary modality.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Lu MD, Jing MD, PhD, Weihong PhD, Yi MD, Zhoufang MD, Hongbo PhD, Jie MD, Guiling MD, Zehua MD, PhD,